Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
1 raison identifiée
Auteur de référence en rhumatologie
50 articles scientifiques publiés — un praticien à la pointe de la recherche
✨ Génération du profil synthétique IA en cours…
🎓 DES & spécialité ordinale
📚 CES (Certificat d'Études Spéciales)
🎓 Diplômes
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
Abstract INTRODUCTION Detection of Alzheimer's disease (AD) pathophysiology among individuals with mild cognitive changes and those experiencing subjective cognitive decline (SCD) remains challenging. Plasma phosphorylated tau 217 (p‐tau217) is one of the most promising of the emerging biomarkers for AD. However, accessible methods are limited. METHODS We employed a novel p‐tau217 immunoassay (University of Gothenburg [UGOT] p‐tau217) in four independent cohorts ( n = 308) including a cerebrospinal fluid (CSF) biomarker‐classified cohort (Discovery), two cohorts consisting mostly of cognitively unimpaired (CU) and mild cognitively impaired (MCI) participants (MYHAT and Pittsburgh), and a population‐based cohort of individuals with SCD (Barcelonaβeta Brain Research Center's Alzheimer's At‐Risk Cohort [β‐AARC]). RESULTS UGOT p‐tau217 showed high accuracy (area under the curve [AUC] = 0.80–0.91) identifying amyloid beta (Aβ) pathology, determined either by Aβ positron emission tomography or CSF Aβ42/40 ratio. In individuals experiencing SCD, UGOT p‐tau217 showed high accuracy identifying those with a positive CSF Aβ42/40 ratio (AUC = 0.91). DISCUSSION UGOT p‐tau217 can be an easily accessible and efficient way to screen and monitor patients with suspected AD pathophysiology, even in the early stages of the continuum.
Molecular neurodegeneration · 2024
AbstractAlzheimer’s disease (AD), the most common form of dementia, remains challenging to understand and treat despite decades of research and clinical investigation. This might be partly due to a lack of widely available and cost-effective modalities for diagnosis and prognosis. Recently, the blood-based AD biomarker field has seen significant progress driven by technological advances, mainly improved analytical sensitivity and precision of the assays and measurement platforms. Several blood-based biomarkers have shown high potential for accurately detecting AD pathophysiology. As a result, there has been considerable interest in applying these biomarkers for diagnosis and prognosis, as surrogate metrics to investigate the impact of various covariates on AD pathophysiology and to accelerate AD therapeutic trials and monitor treatment effects. However, the lack of standardization of how blood samples and collected, processed, stored analyzed and reported can affect the reproducibility of these biomarker measurements, potentially hindering progress toward their widespread use in clinical and research settings. To help address these issues, we provide fundamental guidelines developed according to recent research findings on the impact of sample handling on blood biomarker measurements. These guidelines cover important considerations including study design, blood collection, blood processing, biobanking, biomarker measurement, and result reporting. Furthermore, the proposed guidelines include best practices for appropriate blood handling procedures for genetic and ribonucleic acid analyses. While we focus on the key blood-based AD biomarkers for the AT(N) criteria (e.g., amyloid-beta [Aβ]40, Aβ42, Aβ42/40 ratio, total-tau, phosphorylated-tau, neurofilament light chain, brain-derived tau and glial fibrillary acidic protein), we anticipate that these guidelines will generally be applicable to other types of blood biomarkers. We also anticipate that these guidelines will assist investigators in planning and executing biomarker research, enabling harmonization of sample handling to improve comparability across studies.
Nature communications · 2023
Abstract The vitamin D binding protein (DBP), encoded by the group-specific component ( GC ) gene, is a component of the vitamin D system. In a genome-wide association study of DBP concentration in 65,589 neonates we identify 26 independent loci, 17 of which are in or close to the GC gene, with fine-mapping identifying 2 missense variants on chromosomes 12 and 17 (within SH2B3 and GSDMA , respectively). When adjusted for GC haplotypes, we find 15 independent loci distributed over 10 chromosomes. Mendelian randomization analyses identify a unidirectional effect of higher DBP concentration and (a) higher 25-hydroxyvitamin D concentration, and (b) a reduced risk of multiple sclerosis and rheumatoid arthritis. A phenome-wide association study confirms that higher DBP concentration is associated with a reduced risk of vitamin D deficiency. Our findings provide valuable insights into the influence of DBP on vitamin D status and a range of health outcomes.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026 · Journal Article
Kennedy JT, Wisch JK, Boerwinkle AH, Millar PR, et al.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026 · Clinical Trial, Phase II
Cohen A, Kamanda-Kosseh M, Rawal R, Agarwal S, et al.
Medicina (Kaunas, Lithuania) · 2025 · Journal Article
Patt YS, Ben-Shabat N, David P, Patt C, et al.
Arthroscopy, sports medicine, and rehabilitation · 2025 · Journal Article
Jordan SE, Anz AW, Ostrander RV 3rd, Branch EA, et al.
Musculoskeletal care · 2025 · Journal Article
Hassan F, Paz Z, Saab A, Cohen AG, et al.
Seminars in arthritis and rheumatism · 2025 · Journal Article
Gérard AL, Vieira M, Cohen A, Hassanaly O, et al.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024 · Journal Article
Agarwal S, El-Najjar D, Kondapalli A, Kil N, et al.
Journal of hand and microsurgery · 2024 · Journal Article
Campbell BR, Cohen AR, Alfonsi S, Depascal M, et al.
The Journal of hand surgery, European volume · 2024 · Journal Article
Cohen A, Reijman M, Selles RW, Hovius SER, et al.
Endocrinology and metabolism clinics of North America · 2024 · Journal Article
Cohen A
Arthroscopy, sports medicine, and rehabilitation · 2024 · Journal Article
Perez AR, Coladonato C, Hanna AJ, Sabitsky M, et al.
Cutis · 2024 · Journal Article
Aronov M, Valdman-Grinshpoun Y, Cohen AD, Freud T, et al.
The Australasian journal of dermatology · 2024 · Letter
Kridin K, Bitterman AK, Jeries H, Hassan F, et al.
Arthritis research & therapy · 2024 · Journal Article
Haddad A, Elkayam PC, Stein N, Feldhamer I, et al.
Molecular neurodegeneration · 2024 · Journal Article
Zeng X, Chen Y, Sehrawat A, Lee J, et al.
Journal of clinical medicine · 2024 · Journal Article
Gendelman O, Simon N, Ben-Shabat N, Patt YS, et al.
Pain · 2024 · Journal Article
Liu PW, Zhang H, Werley CA, Pichler M, et al.
Arthroscopy, sports medicine, and rehabilitation · 2024 · Journal Article
Vadhera AS, Fones L, Johns W, Cohen AR, et al.
Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024 · Journal Article
Gonzalez-Ortiz F, Ferreira PCL, González-Escalante A, Montoliu-Gaya L, et al.
Vaccines · 2024 · Journal Article
Gazitt T, Hayat N, Stein N, Haddad A, et al.
medRxiv : the preprint server for health sciences · 2023 · Preprint
Gonzalez-Ortiz F, Ferreira PCL, Gonzalez A, Montoliu-Gaya L, et al.
Biologics : targets & therapy · 2023 · Journal Article
Haddad A, Stein N, Lavi I, Shynkar L, et al.
Journal of clinical medicine · 2023 · Journal Article
Kagan P, Horesh N, Amital H, Tsur AM, et al.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2023 · Journal Article
Kondapalli AV, Kamanda-Kosseh M, Williams JM, Shiau S, et al.
Life (Basel, Switzerland) · 2023 · Journal Article
Shalata W, Yakobson A, Cohen AY, Goldstein I, et al.
Clinical and experimental rheumatology · 2023 · Journal Article
Savin E, Tsur AM, Watad A, Gendelman O, et al.
Diagnostics (Basel, Switzerland) · 2026 · Journal Article
Ehrenberg S, Elizur Y, Ben-Shabat N, David P, et al.
Rheumatology (Oxford, England) · 2026 · Journal Article
Haddad A, Slutsker B, Stein N, Gazitt T, et al.
Clinical rheumatology · 2024 · Journal Article
Hijazi N, Gazitt T, Haddad A, Elias M, et al.
Bone · 2026 · Journal Article
Lynch L, Shea PR, Vena N, Chung WK, et al.
Science translational medicine · 2024 · Journal Article
Bisikirska B, Labella R, Cuesta-Dominguez A, Luo N, et al.
Nature communications · 2023 · Journal Article
Albiñana C, Zhu Z, Borbye-Lorenzen N, Boelt SG, et al.
Calcified tissue international · 2026 · Systematic Review
Weckerly ML, Feingold CL, Singh NK, Fatehi MK, et al.
Orthopedics · 2025 · Journal Article
Weckerly M, Cohen A, Grubman O, Cooper AR
International journal of dermatology and venereology · 2023 · Journal Article
Cohen AJ, Gleason LK, Bhatti SA, Nikbakht N
Seminars in arthritis and rheumatism · 2025 · Journal Article
Haddad A, Stein N, Feldhamer I, Cohen AD, et al.
Vaccines · 2024 · Journal Article
Gazitt T, Eder L, Saliba W, Stein N, et al.
Expert opinion on drug safety · 2024 · Journal Article
Schwartzman S, Puig L, Cohen AD, Khattri S, et al.
International journal of dermatology and venereology · 2023 · Journal Article
Cohen AJ, Gleason LK, Bhatti SA, Nikbakht N
The Israel Medical Association journal : IMAJ · 2025 · Journal Article
Varda B, Zur AD, Kuntzman Y, Patt YS, et al.
Orthopaedic journal of sports medicine · 2023 · Journal Article
Anz AW, Jordan SE, Ostrander RV 3rd, Branch EA, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2023 · Letter
Kridin K, Abou Amara Y, Barhoum M, Cohen AD
Postgraduate medicine · 2024 · Journal Article
David P, Houri Levi E, Feifel A, Patt YS, et al.
The Journal of clinical endocrinology and metabolism · 2025 · Journal Article
Kamanda-Kosseh M, Shiau S, Agarwal S, Kondapalli A, et al.
The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2024 · Journal Article
Buszkiewicz JH, Xie Y, Cohen A, Vander Woude C, et al.
Calcified tissue international · 2026 · Systematic Review
Weckerly ML, Feingold CL, Singh NK, Fatehi MK, et al.
European journal of preventive cardiology · 2026 · Journal Article
Guedon AF, Espitia O, Beydon M, Ghrenassia E, et al.
RMD open · 2023 · Multicenter Study
Guedon AF, Ricard L, Laurent C, De Moreuil C, et al.
Internal medicine journal · 2024 · Journal Article
Cohen A, Weerasinghe N, Lemmert K, de Malmanche T, et al.
Postgraduate medical journal · 2023 · Journal Article
Eid S, Sharif K, McGonagle D, Patt YS, et al.
Medicina clinica · 2023 · Journal Article
Sharif K, Tsur AM, Ben-Shabat N, Watad A, et al.
Kidney360 · 2023 · Journal Article
Waldman M, Sinaii N, Lerma EV, Kurien AA, et al.
✨ Profil synthétique
IA · 15/05/2026Le Docteur Anne Christine Cohen est un rhumatologue dont les publications sur PubMed couvrent divers aspects de la rhumatologie, notamment l'épidémiologie, la génétique et l'utilisation de l'anti-IL-17. Ses travaux incluent également des études de cas et des revues générales. Cette variété de sujets suggère une approche globale de la rhumatologie.
Expertises présumées
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.